Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs
Credelio Quattro administered once orally at the minimum dosages of 20 mg/kg of lotilaner, 0.02 mg/kg of moxidectin, 5.0 mg/kg of praziquantel and 5.0 mg/kg of pyrantel was safe and effective for the treatment and control of adult E. granulosus and E. multilocularis in dogs.
Authors
- Lisa Young (ORCID: https://orcid.org/0000-0001-8804-4152)
- Gertraut Altreuther
- Michael Ulrich
- Scott Wiseman (ORCID: https://orcid.org/0000-0002-0269-6684)
- Daniel E. Snyder (ORCID: https://orcid.org/0000-0002-4091-6297)
- Padraig Doherty
- Craig R. Reinemeyer (ORCID: https://orcid.org/0000-0002-7641-3042)
- Samuel Charles
- Xinshuo Wang
Institutions
- Western Texas College (US)
- Allergan (Ireland) (IE)
- East Tennessee Clinical Research (US)
- Elanco (United States) (US)
Publication Details
- Journal
- Parasites & Vectors
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1186/s13071-025-06735-w
- Primary Topic
- Parasitic infections in humans and animals
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Elanco Animal Health